GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75N93024C00021INSTITUT DE FORMULATION DES VACCINS (CH) SA

Overview

Award facts

Net obligations
$1.56M
$1,563,776of $9.19M potential value
Outlays (paid to date)
$1.02M
$1.02M paid of $1.56M obligated$1,022,120
Period of performance
Sep 30, 2024 to Apr 15, 2025
Ended
Modifications
2
Latest action Apr 15, 2025
Contract type
Definitive contract
PIID 75N93024C00021

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

VACCINE ADJUVANT DISCOVERY PROGRAM

Dates and value

Award date
Signed on Sep 19, 2024
Potential end of performance
Apr 14, 2025
Current value
$1,563,776Base and exercised options
Potential value (if all options are exercised)
$9,189,961

Obligations by fiscal year of action

  • FY2024: $1,563,776

Total across 1 fiscal year: $1,563,776

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Apr 15, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationPLAN-LES-OUATES, CHE
UEIN773KSZMJA78
CAGE codeSMVP9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt

Business types and certifications

Nonprofit organizationLimited liability companyTax-exempt corporation

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Switzerland

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost no feeS
Offers received
13

Solicitation and notices

Solicitation ID
75N93022R00022(as reported)
Solicitation date
Dec 20, 2022

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
Yes - service where PBA is used.Y

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 19, 2024Base obligation at award: $1,563,776
Latest action
Apr 15, 2025 — Terminated for convenienceModification P00002
Latest substantive action
Apr 15, 2025 — Terminated for convenienceModification P00002
Actions by type
  • Base award1
  • Terminated for convenience1
  • Other administrative action1
3 actions recorded, Sep 19, 2024 to Apr 15, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Foreign-owned business not incorporated in the U.S.D
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
3

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2024/2024-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression